The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.
October 2025
Cover Story & Features
At the most fundamental level, diabetic retinopathy (DR) is a metabolic disease of the retina. When excessive glucose is present in the blood stream—as is the case with poorly controlled type 1, type 2, and gestational diabetes—several metabolic pathways are upregulated to handle the hyperglycemic state.
Like many other dietary supplements, herbal supplements (HSs) continue to receive enormous attention from competitive and recreational athletes.
Regenerative agriculture is the new buzz word in sustainable farming. But what does it really mean? Does it do all it promises? How can food and nutrition experts sort facts from hype and help clients do the same?
Metabolic syndrome (MetS) is a collection of disorders that include abdominal obesity, hypertension (HTN), dyslipidemia including high triglycerides (TGs) and/or low HDL cholesterol, and impaired glucose metabolism (elevated fasting blood glucose).
Departments
